Telogen effluvium

L12_TELOGEFFLU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L65.0# Cause of death: ICD-10 — L65.0# 2 out of 7 registries used, show all original rules.	85
4. Check minimum number of events None	85
5. Include endpoints None	85
6. Filter based on genotype QC (FinnGen only)	78

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L65
Name in latin: Effluvium telogenicum

NAME	L12_TELOGEFFLU
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L650
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L650
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Telogen effluvium based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	541	499	35
Only index persons	520	488	32
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.02	0.02	0.00
Median age at first event (years)
Whole population	37.78	39.08	18.84
Only index persons	38.14	39.45	18.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	78	71	7
Unadjusted period prevalence (%)	0.02	0.03	0.00
Median age at first event (years)	51.98	52.59	45.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
80: Matched controls
800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L65.0

ICD-10 Finland

Telogen effluvium

+∞

115.1

C03DA01

ATC

spironolactone; oral

6.9

12.4

D07AC01

ATC

betamethasone; topical

4.6

10.4

197

L65.9

ICD-10 Finland

Nonscarring hair loss, unspecified

112.8

9.6

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020717) Zinc [Moles/volume] in Serum or Plasma

13.85

7.36

1.1

1.0

17.86

21.20

umol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

11.07

5.17

1.2

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

174

2.80

4.71

2.5

2.3

1.95

2.78

mg/l

2.36

146

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

693

+∞

4.42

23.7

15.3

21.39

17.94

mg/l

0.39

551

(3019309) Folate [Moles/volume] in Red Blood Cells

110

2.85

4.16

1.6

1213.04

1100.97

nmol/l

0.19

(40768797) Stomach Pathology biopsy report

105

2.84

4.02

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

207

2.47

3.75

1.4

1.2

1.13

1.96

u/ml

0.42

(3022145) Colonoscopy Study observation

2.92

3.63

1.4

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

6.70

3.60

1.0

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

119

2.60

3.52

1.5

1013.33

638.71

titre

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.49

3.48

1.0

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

7.99

3.11

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

206

2.24

3.03

1.5

1.6

21.52

20.42

nmol/l

0.14

171

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

4.81

2.88

4.0

2.3

2.66

3.53

g/l

—

(3001604) Monocytes [#/volume] in Blood

375

2.22

2.84

9.1

6.1

0.52

0.54

e9/l

0.28

332

(4062490) Immunoglobulin typing, IgG

8.78

2.79

1.0

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

179

2.19

2.77

1.4

1.3

12.91

22.95

iu/ml

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.26

2.77

1.8

1.4

—

(42870588) Differential panel, method unspecified - Blood

247

2.13

2.76

9.1

5.8

—

(3006315) Basophils [#/volume] in Blood

379

2.18

2.72

9.2

6.1

0.05

0.04

e9/l

1.08

333

(3019198) Lymphocytes [#/volume] in Blood

389

2.19

2.72

9.1

6.0

1.84

1.89

e9/l

0.22

354

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2.85

2.59

5.2

3.9

4.18

4.49

pmol/l

0.83

(3013115) Eosinophils [#/volume] in Blood

394

2.14

2.56

9.6

6.6

0.21

0.17

e9/l

0.94

356

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

160

2.15

2.54

5.7

1.8

1.39

1.13

mg/l

0.18

126

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

4.89

2.31

1.0

2.8

10.88

10.15

mg/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.12

2.30

2.6

2.1

—

(3018418) pH of Serum or Plasma

216

2.00

2.29

8.9

3.5

7.39

7.40

0.63

149

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

4.54

2.19

1.5

1.1

—

(3002256) Pathology report gross observation

2.23

2.18

1.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.73

2.11

5.1

1.9

170.29

174.20

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

171

1.98

2.08

1.3

24.59

6.53

u/ml

0.34

(40768804) Tissue Pathology biopsy report

299

1.85

1.94

3.4

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.95

1.85

1.5

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

421

1.87

1.82

10.6

10.7

3.84

4.04

e9/l

0.31

374

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

3.51

1.78

6.7

1.6

11.75

5.04

pmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

324

1.80

1.77

2.6

2.0

102.29

100.46

pmol/l

0.08

153

(40768443) Skin Pathology biopsy report

3.09

1.76

1.1

—

(3015736) pH of Urine

325

1.79

1.74

3.0

3.4

6.46

6.29

0.50

175

(3007164) IgA [Mass/volume] in Serum or Plasma

182

1.83

1.68

1.6

1.3

2.87

2.12

g/l

1.22

100

(40761535) Cells panel - Urine sediment

2.51

1.66

6.9

3.1

—

(3021589) Normoblasts [#/volume] in Blood

330

1.74

1.62

15.6

9.7

0.00

e9/l

-0.00

266

(3035350) Ketones [Presence] in Urine by Test strip

400

1.76

1.59

3.9

3.8

0.00

estimate

-0.00

(3042936) Bacteria identified in Isolate by Culture

2.00

1.58

2.2

2.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2.08

1.57

15.9

5.6

1.04

1.07

mmol/l

0.14

(3007853) Bacteria identified in Skin by Aerobe culture

2.05

1.52

1.3

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

242

1.70

1.47

4.4

3.1

—

(3022313) Gas panel - Capillary blood

2.86

1.46

4.3

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

397

1.69

1.42

3.7

3.8

0.00

estimate

-0.00

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.73

1.39

1.2

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

2.73

1.39

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

227

1.68

1.39

2.8

2.1

152.41

137.89

u/l

0.09

222

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.06

1.38

1.8

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

150

1.75

1.34

2.2

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.62

1.33

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.62

1.33

1.7

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

343

1.63

1.31

3.2

3.0

—

estimate

—

(3023368) Bacteria identified in Blood by Culture

160

1.71

1.29

5.3

4.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

297

1.61

1.26

2.8

3.6

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

405

1.63

1.25

3.9

0.00

estimate

-0.00

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.41

1.21

2.0

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.41

1.21

1.2

2.0

0.25

0.22

g/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

513

1.68

1.17

4.0

3.5

—

(3026008) Bacteria identified in Urine by Culture

236

1.59

1.16

7.4

3.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.30

1.11

3.6

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.01

1.06

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.09

1.03

1.7

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.90

1.00

1.2

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

769

+∞

0.98

34.0

22.8

131.60

133.13

g/l

0.58

762

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

769

+∞

0.98

34.3

23.1

39.74

40.02

0.32

762

(3026361) Erythrocytes [#/volume] in Blood

769

+∞

0.98

33.9

22.6

4.36

4.44

e12/l

1.16

756

(3010813) Leukocytes [#/volume] in Blood

769

+∞

0.98

34.0

22.6

6.73

6.52

e9/l

0.44

756

(3035941) MCH [Entitic mass]

769

+∞

0.98

33.8

22.5

30.44

30.15

0.83

762

(36660697) Celiac disease serology panel - Serum

1.80

0.98

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

111

1.67

0.98

2.0

1.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

768

+∞

0.97

33.8

22.6

91.54

90.80

0.70

761

(3007461) Platelets [#/volume] in Blood

768

+∞

0.97

34.1

22.6

266.51

261.99

e9/l

0.22

759

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

254

1.51

0.96

2.8

3.4

12.98

18.61

ng/l

1.41

155

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

181

1.55

0.96

1.4

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.32

0.96

3.3

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.32

0.96

3.3

2.1

—

(3003694) ABO and Rh group [Type] in Blood

229

1.50

0.90

1.6

—

(4024509) Urine culture

2.01

0.86

2.7

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

115

1.61

0.86

8.9

3.7

0.81

0.80

mmol/l

0.07

108

(3000494) Fungus identified in Specimen by Culture

1.67

0.85

1.8

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

168

1.52

0.84

2.9

2.5

—

(3020891) Body temperature

0.00

0.80

0.0

3.6

—

36.90

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.80

0.0

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.79

0.80

4.2

3.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.80

0.0

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

225

1.45

0.79

3.0

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

109

0.51

0.79

1.8

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

109

1.58

0.78

3.3

2.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.75

0.78

6.1

8.8

1.87

1.09

mmol/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.76

0.76

2.1

1.6

—

(4035726) Immunohistochemistry procedure

1.76

0.76

1.8

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

183

1.44

0.71

7.8

3.2

947.17

733.55

ng/l

0.16

152

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

596

1.48

0.63

27.4

18.6

13.69

13.57

0.36

589

(3041096) Erythrocytes [Presence] in Urine by Automated

225

1.38

0.61

2.5

3.2

0.00

estimate

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.61

0.0

2.7

—

1.40

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.61

0.0

1.7

—

24.96

—

(3030467) Casts [#/volume] in Urine by Automated count

198

1.38

0.59

4.9

3.2

0.27

0.39

e6/l

0.34

134

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.62

0.58

1.2

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.72

0.58

7.7

2.8

25.98

24.86

mmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

237

1.35

0.57

5.0

3.2

39.67

21.16

e6/l

0.36

171

(3000492) Spirometry study

1.56

0.57

1.6

1.5

—

(3018095) Leukocytes [#/volume] in Urine

276

1.33

0.55

6.1

4.2

34.14

41.34

e6/l

0.11

182

(3050129) First trimester maternal screen panel - Serum or Plasma

1.62

0.55

1.5

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.58

0.54

8.0

7.6

24.13

24.56

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

101

1.47

0.54

2.1

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

110

1.45

0.53

4.1

3.4

5.63

4.99

e6/l

—

(3025941) Bacteria identified in Stool by Culture

1.61

0.50

2.3

1.0

—

(36304419) Bacteria [Presence] in Urine

194

1.34

0.50

4.3

3.0

—

estimate

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.57

0.50

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

176

1.34

0.49

5.2

5.0

—

(40758558) Short blood count panel - Blood

234

1.30

0.46

10.3

7.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.65

0.44

1.2

1.7

—

8.30

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.41

3.9

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.47

0.41

3.1

2.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.40

0.0

2.7

—

3.92

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.46

0.40

1.4

1.3

—

(1002224) Polysomnography panel

1.41

0.39

1.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

192

1.28

0.38

2.2

1.6

—

(3012516) Albumin [Mass/volume] in Urine

203

1.26

0.35

3.4

3.0

28.49

38.54

mg/l

0.24

120

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

119

1.32

0.35

5.1

3.2

0.25

0.98

e6/l

—

(3029937) Albumin [Presence] in Urine by Test strip

204

1.25

0.34

3.2

3.9

0.00

estimate

-0.00

(3000991) Gas panel - Venous blood

1.35

0.32

10.0

9.4

—

(3023520) Reticulocytes [#/volume] in Blood

1.27

0.30

3.0

3.5

77.91

73.30

e9/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.36

0.30

3.1

2.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.26

0.28

5.8

2.7

5.52

5.76

kpa

—

(3002032) Base excess in Venous blood by calculation

1.24

0.28

5.8

2.6

1.67

2.02

mmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.32

0.25

4.2

5.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.34

0.23

1.2

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.21

0.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

3.90

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.21

0.0

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

107.80

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

2.0

—

1.20

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.3

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.4

—

10.08

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

1.5

—

91.22

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

4.7

—

94.34

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.17

0.19

3.7

2.6

8.43

4.24

kpa

—

(40761536) Microorganisms panel - Urine sediment

1.25

0.19

3.0

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

208

1.15

0.16

3.9

3.5

10.02

6.61

mg/mmol

0.23

117

(46235355) HIV 1 and 2 tests - Meaningful Use set

185

1.11

0.09

2.8

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.08

0.09

5.5

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.08

0.09

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1.12

0.08

2.0

2.86

3.63

mmol/l

—

(3003396) Base excess in Arterial blood by calculation

0.83

0.08

6.5

15.5

0.30

1.25

mmol/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

0.84

0.07

8.3

7.0

103.13

104.28

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

290

0.95

0.04

3.8

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

702

0.98

0.00

5.6

4.7

5.60

5.74

mmol/l

0.67

649

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

125

0.95

0.00

2.9

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

114

0.96

0.00

3.1

2.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

95.74

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

63.20

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.4

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.1

—

67.88

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.6

—

(4198724) Urine methamphetamine measurement

0.00

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

18.6

—

1012.29

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

0.29

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

26.3

—

1946.86

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

3.2

—

0.60

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

83.40

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.3

—

7.14

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.70

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.3

—

4.56

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.3

—

10.64

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.0

—

31.88

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.95

-0.00

2.3

1.9

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.2

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.3

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

12.23

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.90

-0.00

2.0

2.1

3.07

3.33

ratio

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.97

-0.00

1.7

1.5

1047.83

965.30

mu/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_TELOGEFFLU and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_TELOGEFFLU.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_TELOGEFFLU – Telogen effluvium

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Telogen effluvium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints